FTC Files Amicus Brief to Protect Consumers from Pharmaceutical Monopolies
By
vgraham
Source
bulkorder.ftc.govFTC Files Amicus Brief to Protect Consumers from Pharmaceutical Monopoliesftc.govYou might also wanna read
FTC expands antitrust probe into Microsoft's cloud, AI, and software bundling practices
The US Federal Trade Commission (FTC) is expanding its antitrust investigation into Microsoft, examining the company's business agreements,
cio.com·1mo ago
FTC Proposes Policy Statement Targeting AI Accuracy and Deceptive Practices, Seeks Public Comment
The Federal Trade Commission (FTC) is requesting public comment on a proposed policy statement that addresses concerns about AI companies po
bulkorder.ftc.gov·3d agoFTC Proposes Policy Statement Targeting AI Accuracy and Deceptive Practices, Seeks Public Comment
The Federal Trade Commission (FTC) is requesting public comment on a proposed policy statement that addresses concerns about AI companies po
ftc.gov·3d ago
Unsealed FTC Documents Reveal Alleged Price-Fixing Arrangement Between Pepsi and Walmart
The article reveals previously sealed documents showing Pepsi and Walmart allegedly colluded to raise food prices across the economy. Accord
thebignewsletter.com·6mo ago
FTC Seeks Public Comments on AI Model Bias and Objectivity
The U.S. Federal Trade Commission (FTC), under a Trump administration majority, is seeking public comments on AI model behavior, specificall
govinfosecurity.com·2d ago
Big Tech spends millions to defeat California antitrust bill targeting monopolistic practices
Silicon Valley and Big Tech companies are spending millions to defeat a landmark California bill that would expand state regulations against
jacobin.com·4d agoBig Tech spends millions to defeat California antitrust bill targeting monopolistic practices
Silicon Valley and Big Tech companies are spending millions to defeat a landmark California bill that would expand state regulations against
jacobin.com·4d ago
Research Reveals Persistent Drug Pricing Distortions from PBM-Owned Pharmaceutical Companies
The article examines the persistent distortions in U.S. drug pricing, particularly focusing on vertically integrated pharmacy benefit manage
46brooklyn.com·7mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.